))
027 Hello Tomorrow AP 2023 BioTech: BioScan Research, OsseoLabs, 6J Biotechnology and Pending AI
Manage episode 388225975 series 3467754
Content provided by A*StartCentral. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by A*StartCentral or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
This is One North Stories, an A*START CENTRAL Podcast
Hello Tomorrow Asia Pacific Summit happened on 27th September 2023 at the National Gallery in Singapore. This episode contains interviews with three finalists: Bioscan Research (6:24), OsseoLabs (14:40) and 6J BioTechnology (20:37) plus another company we met, Pending AI (31:10).
Shilpa from Bioscan Research shares about their technology for non invasive, early detection of bleeding in the brain.
Patcharapit from OsseoLabs shares about developing and scaling technology for 3D printed medical implants.
Qingru from 6J BioTechnology (Hong Kong) Ltd shares about the early stages of leading a drug discovery company with an initial focus on 2 small molecules that inhibit metastasis and promote immune response.
David Cardoso from Pending AI shares about the drug discovery platform they are developing, leveraging AI for discovery and exploration and quantum when you want specificity.
Tune into future episodes sharing our interviews with more of the Hello Tomorrow APAC Challenge 2023 Finalists.
Thank you for listening. If you like what you’ve heard, please subscribe and review us wherever you get your podcasts.
Check out A*START CENTRAL (Website, LinkedIn)
If you have future episode ideas, segments ideas or want to partner with us on this exciting journey, please get in touch: onenorthstories@hq.a-star.edu.sg
38 episodes
Share
